In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone (Q42112686)

16 October 2017

In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone (English)

1 reference

16 October 2017

0 references

Katsuko Fujikawa

1

1 reference

16 October 2017

Megumi Chiba

series ordinal

2

1 reference

16 October 2017

Mayumi Tanaka

series ordinal

3

1 reference

16 October 2017

Kenichi Sato

series ordinal

4

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Antimicrobial Agents and Chemotherapy

16 October 2017

1 reference

16 October 2017

49

1 reference

16 October 2017

7

1 reference

16 October 2017

3040-3045

1 reference

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Antimicrobial resistance trends and outbreak frequency in United States hospitals

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

The antibacterial action of vancomycin.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

In vitro susceptibilites to levofloxacin and various antibacterial agents of 11,475 clinical isolates obtained from 52 centers in 2002

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Vancomycin-resistant Staphylococcus aureus--New York, 2004.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Vancomycin-resistant enterococci in King Chulalongkorn Memorial Hospital: a 5-year study.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Infectious disease 2001: drug resistance, new drugs

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168666

Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15980395

12 December 2020

inferred from PubMed ID database lookup

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15980395

12 December 2020

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980395

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.49.7.3040-3045.2005

1 reference

release_chvk4jivzzfphixpufp6ybrqve

16 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/chvk4jivzzfphixpufp6ybrqve

24 November 2022

mapped directly with Wikidata item

1 reference

16 October 2017

PubMed publication ID

15980395

1 reference